The life-saving role played by Indian pharmaceutical firms in poorer countries of Africa is one of the real global success stories of our time.
The year: 2001. Africa was facing a major health crisis. Sub-Saharan Africa alone had 22.5 million HIV-positive people. The disease was assuming epidemic proportions. The price of patented drugs supplied by western drug companies was a prohibitive $10,000 per patient per year – way out of reach of the average patient.
Sign-up for full access to India Global Business. It's FREE